Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 11, 2018 - Issue
Submit an article Journal homepage
91
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

Moshe Ashkenazi1 Pediatric Pulmonology and National CF Center, Edmond and Lilly Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
,
Saray Sity2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Ifat Sarouk1 Pediatric Pulmonology and National CF Center, Edmond and Lilly Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Bat El Bar Aluma1 Pediatric Pulmonology and National CF Center, Edmond and Lilly Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Adi Dagan1 Pediatric Pulmonology and National CF Center, Edmond and Lilly Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Yael Bezalel1 Pediatric Pulmonology and National CF Center, Edmond and Lilly Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Lea Bentur3 Pediatric Pulmonology Institute, Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel
,
Kris De Boeck4 Pediatric Pulmonology, Department of Pediatrics, University of Leuven, Leuven, Belgium
&
Ori Efrati1 Pediatric Pulmonology and National CF Center, Edmond and Lilly Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel;2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
 show all
Pages 101-107 | Published online: 19 Jun 2018

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sophie Steels, Marijke Proesmans, Xavier Bossuyt, Lieven Dupont & Glynis Frans. (2023) Laboratory biomarkers in the diagnosis and follow-up of treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Critical Reviews in Clinical Laboratory Sciences 60:1, pages 1-24.
Read now

Articles from other publishers (21)

Huy Duc Vu, Eskandarain Shafuddin, Jane Willis, Michael Pallin, David Armstrong & Christopher Daley. (2023) Monoclonal antibody therapy in cystic fibrosis and asthma. Respirology 28:6, pages 571-574.
Crossref
Meiling Jin, Jo A. Douglass, J. Stuart Elborn, Ritesh Agarwal, William J. Calhoun, Slawomir Lazarewicz, Xavier Jaumont & Meng Yan. (2023) Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:3, pages 896-905.
Crossref
Apeksha Koul, Rajesh K. Bawa & Yogesh Kumar. (2022) Artificial Intelligence Techniques to Predict the Airway Disorders Illness: A Systematic Review. Archives of Computational Methods in Engineering 30:2, pages 831-864.
Crossref
Sara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, Maria Papale, Enza Mulè, Donatella Aloisio, Novella Rotolo & Salvatore Leonardi. (2022) Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review. European Respiratory Review 31:165, pages 220011.
Crossref
Ritesh Agarwal, Valliappan Muthu, Inderpaul S. Sehgal, Sahajal Dhooria, Kuruswamy T. Prasad & Ashutosh N. Aggarwal. (2022) Allergic Bronchopulmonary Aspergillosis. Clinics in Chest Medicine 43:1, pages 99-125.
Crossref
Madeline G. Tompkins & Rebecca Pettit. (2021) Beyond the Guidelines: Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis. Annals of Pharmacotherapy 56:2, pages 181-192.
Crossref
永梅 魏. (2022) Clinical Efficacy of Omalizumab in the Treatment of Allergic Pulmonary Aspergillosis: A Meta-Analysis. Advances in Clinical Medicine 12:11, pages 10480-10488.
Crossref
Evan Li, Antony Rodriguez, Amber U Luong, David Allen, John Morgan Knight, Farrah Kheradmand & David B Corry. (2021) The immune response to airway mycosis. Current Opinion in Microbiology 62, pages 45-50.
Crossref
Aidan K. Curran & David L. Hava. (2021) Allergic Diseases Caused by Aspergillus Species in Patients with Cystic Fibrosis. Antibiotics 10:4, pages 357.
Crossref
Chad R. Marion, Manuel Izquierdo, Holly C. Hanes & Christopher Barrios. (2021) Asthma in Cystic Fibrosis: Definitions and Implications of This Overlap Syndrome. Current Allergy and Asthma Reports 21:2.
Crossref
Thomas J Williams, Sunshine Harvey & Darius Armstrong-James. (2020) Immunotherapeutic approaches for fungal infections. Current Opinion in Microbiology 58, pages 130-137.
Crossref
Quovadis J. Epps, Kevin L. Epps, Jeffery T. Zobell & David C. Young. (2020) Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:  II. Therapies for allergic bronchopulmonary aspergillosis. Pediatric Pulmonology 55:12, pages 3541-3572.
Crossref
Birce Sunman, Dilber Ademhan Tural, Beste Ozsezen, Nagehan Emiralioglu, Ebru Yalcin & Uğur Özçelik. (2020) Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis. Frontiers in Pediatrics 8.
Crossref
Vincent D. Giacalone, Brian S. Dobosh, Amit Gaggar, Rabindra Tirouvanziam & Camilla Margaroli. (2020) Immunomodulation in Cystic Fibrosis: Why and How?. International Journal of Molecular Sciences 21:9, pages 3331.
Crossref
Isabel C. Eraso, Saveria Sangiovanni, Eliana I. Morales & Liliana Fernández-Trujillo. (2020) Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review. Therapeutic Advances in Respiratory Disease 14, pages 175346662096164.
Crossref
Paola Rogliani, Maurizia Sforza & Luigino Calzetta. (2020) The impact of comorbidities on severe asthma. Current Opinion in Pulmonary Medicine 26:1, pages 47-55.
Crossref
Angela Koutsokera, Sophie Corriveau, Jenna Sykes, Adele Coriati, Daniel Cortes, Peter Vadas, Cecilia Chaparro, Kieran McIntyre, Elizabeth Tullis & Anne L. Stephenson. (2020) Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis. Journal of Cystic Fibrosis 19:1, pages 119-124.
Crossref
Valliappan Muthu & Ritesh Agarwal. 2020. Clinical Practice of Medical Mycology in Asia. Clinical Practice of Medical Mycology in Asia 137 164 .
Micheál Mac Aogáin, Céline Vidaillac & Sanjay H. Chotirmall. 2020. Cystic Fibrosis. Cystic Fibrosis 93 126 .
Giuseppe Fabio Parisi, Anna Portale, Maria Papale, Lucia Tardino, Novella Rotolo, Amelia Licari & Salvatore Leonardi. (2019) Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review. The Journal of Allergy and Clinical Immunology: In Practice 7:5, pages 1636-1638.
Crossref
Hironobu Tsubouchi, Shinpei Tsuchida, Shigehisa Yanagi, Takafumi Shigekusa, Mariko Miura, Kenjiro Sakaguchi, Nobuhiro Matsumoto & Masamitsu Nakazato. (2019) Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection. Respiratory Medicine Case Reports 28, pages 100875.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.